Phase III COVID-19 vaccine study seeking volunteers in Cleveland and dozens of other US cities – News 5 Cleveland

CLEVELAND Cleveland is among dozens of cities where researchers need volunteers to participate in a Phase III clinical trial to evaluate the efficacy, safety, and immunogenicity of mRNA-1273 to prevent COVID-19, according to ClinicalTrials.gov.

The lead sponsor of the study, ModernaTX, Inc. announced it needs 30,000 participants from various cities, including Cleveland and Cincinnati.

A Phase III trial is the final phase in a vaccine's development before it is approved and licensed, during which the vaccine is given to thousands of people and tested for efficacy and safety, according to the CDC.

The study is scheduled to begin on July 27, with an estimated completion date on October 27, 2022.

Anyone 18 and up is eligible to participate in the study. Other criteria includes:

Inclusion Criteria:

Rapid Medical Research is the only local place participating in the Moderna study. It says it will be actively recruiting 300 people from Northeast Ohio.

"You could really be part of a life-saving, world saving vaccination, said Jade Svoboda, the recruitment manager at Rapid Medical Research.

Each participant will meet with a team of doctors seven times over 25 months, according to Svoboda. The Beachwood based company does compensate its clients.

To get in touch with Rapid Medical Research call 216-508-4400 or head to their website.

To find more information about this study, including exclusion criteria, click here.

If you are interested in participating in the study, contact Moderna Clinical Trials at 855-663-6762 or at clinicaltrials@modernatx.com.

RELATED: Study: Could your blood type indicate severity of COVID-19

Follow this link:

Phase III COVID-19 vaccine study seeking volunteers in Cleveland and dozens of other US cities - News 5 Cleveland